title: Pulmonary hypertension: pathophysiology and signaling pathways.
abstract: Pulmonary hypertension (PH) is characterized by pathological changes to cell signaling pathways within the alveolar-pulmonary arteriole-right ventricular axis that results in increases in pulmonary vascular resistance and, ultimately, the development of right ventricular (RV) dysfunction. Cornerstone histopathological features of the PH vasculopathy include intimal thickening, concentric hypertrophy, and perivascular fibrosis of distal pulmonary arterioles. The presence of plexogenic lesions is pathognomonic of pulmonary arterial hypertension (PAH); when present, this severe form of remodeling is associated with subtotal obliteration of the blood vessel lumen. The extent of RV remodeling in PH correlates with clinical symptom severity and portends a poor outcome. Currently available PH-specific pharmacotherapies that aim to improve symptom burden by targeting pulmonary vasodilatory/vasoconstrictor cell signaling pathways do not fully reverse pulmonary vascular remodeling and, thus, are largely unsuccessful at maintaining normal cardiopulmonary hemodynamics long term. Thus, determining the molecular mechanisms that are responsible for pulmonary vascular remodeling in PH is of great potential therapeutic value, particularly pathways that promote apoptosis-resistant cellular proliferation, disrupt normal cellular bioenergetics to alter cell function, and/or modulate severely abnormal responses to pulmonary vascular injury. This chapter reviews current insights into PH pathophysiology and disease mechanisms, and discusses novel cell signaling pathways that implicate microRNAs and mitochondrial dysfunction in the development of the PH phenotype.
authors.affiliation: Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, 77 Avenue Louis Pasteur, NRB Room 0630-AO, Boston, MA, 02115, USA.
authors.forename: Bradley A
authors.initials: BA
authors.lastname: Maron
authors.forename: Joseph
authors.initials: J
authors.lastname: Loscalzo
mesh_terms: D000818:Animals; D006162:Guanylate Cyclase / Q000502:physiology; D006801:Humans; D006976:Hypertension, Pulmonary / Q000503:physiopathology*; D035683:MicroRNAs / Q000502:physiology; D008928:Mitochondria / Q000502:physiology; D052250:Nitric Oxide Synthase Type III / Q000502:physiology; D015398:Signal Transduction / Q000502:physiology*
chemical_list: D035683:MicroRNAs; D052250:Nitric Oxide Synthase Type III; D006162:Guanylate Cyclase